164 related articles for article (PubMed ID: 23904188)
21. Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family.
Suliman MA; Zhang Z; Na H; Ribeiro AL; Zhang Y; Niang B; Hamid AS; Zhang H; Xu L; Zuo Y
Int J Mol Med; 2016 Sep; 38(3):776-84. PubMed ID: 27460529
[TBL] [Abstract][Full Text] [Related]
22. Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation.
Lanier V; Gillespie C; Leffers M; Daley-Brown D; Milner J; Lipsey C; Webb N; Anderson LM; Newman G; Waltenberger J; Gonzalez-Perez RR
Int J Biochem Cell Biol; 2016 Oct; 79():139-150. PubMed ID: 27590851
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
Pang RT; Leung CO; Ye TM; Liu W; Chiu PC; Lam KK; Lee KF; Yeung WS
Carcinogenesis; 2010 Jun; 31(6):1037-44. PubMed ID: 20351093
[TBL] [Abstract][Full Text] [Related]
24. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
[TBL] [Abstract][Full Text] [Related]
25. In vitro effects of phenytoin and DAPT on MDA-MB-231 breast cancer cells.
Aktas CC; Zeybek ND; Piskin AK
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):680-6. PubMed ID: 26206582
[TBL] [Abstract][Full Text] [Related]
26. Effects of an inhibitor of the γ-secretase complex on proliferation and apoptotic parameters in a FOXL2-mutated granulosa tumor cell line (KGN).
Irusta G; Pazos MC; Abramovich D; De Zúñiga I; Parborell F; Tesone M
Biol Reprod; 2013 Jul; 89(1):9. PubMed ID: 23699387
[TBL] [Abstract][Full Text] [Related]
27. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells.
Xing F; Okuda H; Watabe M; Kobayashi A; Pai SK; Liu W; Pandey PR; Fukuda K; Hirota S; Sugai T; Wakabayshi G; Koeda K; Kashiwaba M; Suzuki K; Chiba T; Endo M; Mo YY; Watabe K
Oncogene; 2011 Sep; 30(39):4075-86. PubMed ID: 21499308
[TBL] [Abstract][Full Text] [Related]
29. The notch signaling system is present in the postnatal pituitary: marked expression and regulatory activity in the newly discovered side population.
Chen J; Crabbe A; Van Duppen V; Vankelecom H
Mol Endocrinol; 2006 Dec; 20(12):3293-307. PubMed ID: 16959876
[TBL] [Abstract][Full Text] [Related]
30. A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling.
Das A; Narayanam MK; Paul S; Mukhnerjee P; Ghosh S; Dastidar DG; Chakrabarty S; Ganguli A; Basu B; Pal M; Chatterji U; Banerjee SK; Karmakar P; Kumar D; Chakrabarti G
J Biol Chem; 2019 Apr; 294(17):6733-6750. PubMed ID: 30824542
[TBL] [Abstract][Full Text] [Related]
31. PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells.
Rehman M; Gurrapu S; Cagnoni G; Capparuccia L; Tamagnone L
PLoS One; 2016; 11(10):e0164660. PubMed ID: 27749937
[TBL] [Abstract][Full Text] [Related]
32. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
Yamaguchi N; Oyama T; Ito E; Satoh H; Azuma S; Hayashi M; Shimizu K; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Ohwada S; Tatsuta K; Inoue J; Semba K; Watanabe S
Cancer Res; 2008 Mar; 68(6):1881-8. PubMed ID: 18339869
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells.
Mitsuhashi Y; Horiuchi A; Miyamoto T; Kashima H; Suzuki A; Shiozawa T
Histopathology; 2012 Apr; 60(5):826-37. PubMed ID: 22348356
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
[TBL] [Abstract][Full Text] [Related]
35. Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs.
Sun DW; Zhang HD; Mao L; Mao CF; Chen W; Cui M; Ma R; Cao HX; Jing CW; Wang Z; Wu JZ; Tang JH
Cell Physiol Biochem; 2015; 37(5):1693-711. PubMed ID: 26545287
[TBL] [Abstract][Full Text] [Related]
36. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
Wang K; Zhang Q; Li D; Ching K; Zhang C; Zheng X; Ozeck M; Shi S; Li X; Wang H; Rejto P; Christensen J; Olson P
Clin Cancer Res; 2015 Mar; 21(6):1487-96. PubMed ID: 25564152
[TBL] [Abstract][Full Text] [Related]
37. miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer.
Jiang L; Lin T; Xu C; Hu S; Pan Y; Jin R
J Cell Mol Med; 2016 Feb; 20(2):313-22. PubMed ID: 26612211
[TBL] [Abstract][Full Text] [Related]
38. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Notch signaling pathway using γ-secretase inhibitor delivered by a low dose of Triton-X100 in cultured oral cancer cells.
Nasrin A; Hassan M; Ye P
Biochem Biophys Res Commun; 2018 Jan; 495(3):2118-2124. PubMed ID: 29253571
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
Wang M; Ma X; Wang J; Wang L; Wang Y
Int J Oncol; 2014 Apr; 44(4):1401-9. PubMed ID: 24535252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
